John Jacobs
Jacobs was appointed Novavax’s CEO due to his commercial skills and track record in launching new pharmaceuticals.
While Jacobs might perform well under normal conditions, Novavax’s significant issues require a turnaround specialist, making his success doubtful.
He ranks above average as a CEO but is unlikely to be a visionary or transformational leader.
By submitting this form, you are agreeing to ManagementTrack’s Privacy Policy. You can choose to opt out of marketing or advertising emails using the ‘unsubscibe’ link included in our emails.
The best
The best
The best
Our investigative journalists interview the top former colleagues of the CEOs you care about.
Our former buysider analysts summarize the key strengths & weaknesses, past successes & failures, and ability to drive value going forward.
You get access to the actual anonymized transcripts and insights.